Funder
Agence Nationale de la Recherche
Association Nationale de la Recherche et de la Technologie
Reference36 articles.
1. Signalling pathways of the TNF superfamily: a double-edged sword;Aggarwal;Nat. Rev. Immunol.,2003
2. Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effects;Alexiou;Arch. Pharmazie,2014
3. Identification of novel peptides against TNF-α using phage display technique and in silico modeling of their modes of binding;Alizadeh;Eur. J. Pharmaceut. Sci.,2017
4. Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System;Center for Drug Evaluation and Research,2017
5. Inhibition Activity of SPD304 on Kinases and Caspases,2019